Related Experiment Video
Updated: Aug 3, 2026
06:23
The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
Young-onset dementia: a practical approach to diagnosis
1Dementia Research Center, Institute of Neurology and Neurosurgery, Queen Square, London, UK.
The Neurologist
|March 21, 2006
Summary
Young-onset dementia (YOD) diagnosis requires a broad approach, unlike Alzheimer's in the elderly. A detailed history and staged laboratory testing are crucial for identifying diverse YOD causes.
Area of Science:
- Neurology
- Geriatrics
- Medical Diagnostics
Background:
- Young-onset dementia (YOD) is defined as dementia presenting before age 65.
- Unlike Alzheimer's disease in older adults, YOD has a wide range of potential causes.
- Identifying the specific cause of YOD is critical for effective management.
Purpose of the Study:
- To review the extensive differential diagnosis for young-onset dementia.
- To provide guidance on utilizing historical data and laboratory findings for diagnosis.
- To outline a staged approach to laboratory testing for YOD.
Main Methods:
- Review of extensive differential diagnoses for young-onset dementia.
- Analysis of historical clues and patterns of cognitive impairment.
- Two-stage laboratory testing strategy: routine "wave 1" and specialized "wave 2" testing.
Main Results:
- Young-onset dementia presents a broad differential diagnosis compared to elderly dementia.
- Historical data, including symptom patterns and family history, offers diagnostic clues.
- Staged laboratory testing aids in identifying both common and rare causes of YOD.
Conclusions:
- A comprehensive diagnostic approach is essential for young-onset dementia.
- Thorough patient history and targeted laboratory investigations are key.
- Coordinated testing can reveal subtle clues for diagnosing diverse YOD etiologies.
Related Concept Videos
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...